Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J‐CARAF) – Report on antiarrhythmic drug therapy
Authors:
- Yuji MurakawaYMYuji Murakawa
- Akihiko NogamiANAkihiko Nogami
- Morio ShodaMSMorio Shoda
- Koichi InoueKIKoichi Inoue
- Shigeto NaitoSNShigeto Naito
- Koichiro KumagaiKKKoichiro Kumagai
- Yasushi MiyauchiYMYasushi Miyauchi
- Teiichi YamaneTYTeiichi Yamane
- Norishige MoritaNMNorishige Morita
- Hideo MitamuraHMHideo Mitamura
- Ken OkumuraKOKen Okumura
Open Access
- 19 October 2013
- journal article
- Published by Wiley in Journal of Arrhythmia
- Vol. 30 (5) , 362-366
Abstract
Background: The Japanese Heart Rhythm Society (JHRS) conducted a nationwide survey of catheter ablation of atrial fibrillation (AF) in Japan, the Japanese Catheter Ablation Registry of Atrial Fibrillation (J‐CARAF). In this report, to offer a perspective on the current status of hybrid AF therapy, we focus on antiarrhythmic drug (AAD) therapy before and after AF ablation.Methods: The JHRS requested electrophysiology centers in Japan to retrospectively register the comprehensive data of each AF ablation session performed in September 2011, March 2012, or September 2012.Results: A total of 179 EP centers submitted data for 3373 sessions. The average patient age was 62.2±10.6 years, and 76.1% (2587) were male. Patients with paroxysmal AF (PAF) consisted of 64.4% of total patients. The average number of AADs used before AF ablation was 1.13±0.96. Among 2173 PAF patients, 454 subjects (20.9%) underwent AF ablation without preceding AAD therapy.At the time of discharge, 40.3% of PAF patients were given one or more AAD, while 63.0% of persistent AF patients and 71.5% of long‐standing‐persistent AF patients left the hospital with an AAD (pp<0.0001). Amiodarone was used in 5.8% of the patients. Among 148 subjects (4.5%) treated with multiple AADs, 131 were taking bepridil.Conclusions: Approximately 20% of PAF ablations were performed without preceding AAD therapy. The post‐procedural AAD regimen was appreciably dependent on the AF type.Keywords
This publication has 10 references indexed in Scilit:
- National survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J‐CARAF)Journal of Arrhythmia, 2013
- Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association surveyEP Europace, 2013
- Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2012
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEP Europace, 2012
- Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablationEP Europace, 2012
- Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)Circulation: Arrhythmia and Electrophysiology, 2011
- Rhythm Control for Management of Patients With Atrial Fibrillation: Balancing the Use of Antiarrhythmic Drugs and Catheter AblationClinical Cardiology, 2011
- Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablationEuropean Heart Journal, 2010
- Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)Circulation, 2009
- Catheter ablation procedures: role of nation-wide registriesEP Europace, 2008